Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

10.35
-0.1600-1.52%
Post-market: 10.440.0907+0.88%16:10 EDT
Volume:421.60K
Turnover:4.40M
Market Cap:177.04M
PE:-2.68
High:10.74
Open:10.44
Low:10.28
Close:10.51
52wk High:16.77
52wk Low:10.28
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.74
T/O Rate:2.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:0.83
PE(LYR):-3.24

Loading ...

Avidity Biosciences Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Jun 18

TransCode Highlights Progress of Lead RNA Cancer Therapeutic

TIPRANKS
·
Jun 18

Atrium Therapeutics initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Jun 18

Circio raises NOK 620 million in 2026 to accelerate circular RNA gene therapy platform

TIPRANKS
·
Jun 10

Sirnaomics Sets EGM to Revamp Equity Incentive Schemes

TIPRANKS
·
Jun 09

Thalia Therapeutics Showcases RNA Strategy in European Biotech Feature

TIPRANKS
·
Jun 09

EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study

Benzinga_recent_news
·
Jun 03

Thalia Therapeutics Showcases Differentiated RNA Strategy and Cardiovascular Candidate

TIPRANKS
·
Jun 02

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire
·
Jun 01

PegBio’s CR059 Wins EASD 2026 Oral Slot, Boosting Circular RNA Metabolic Pipeline

TIPRANKS
·
Jun 01

ValiRx fast-tracks RNA helicase deal with McGill and plans Canadian spin-out

TIPRANKS
·
Jun 01

Circio insiders exercise warrants as company advances circular RNA platform

TIPRANKS
·
May 29

Circio Showcases circVec Data and Opens Discounted Warrant Exercise Window

TIPRANKS
·
May 28

MindWalk Holdings Launches AI-Driven Pandemic Response Platform for RNA Virus Outbreaks

TIPRANKS
·
May 27

Arrowhead presents interim results from Phase 1/2a trial of ARO-INHBE

TIPRANKS
·
May 27

Korro to Present at the 2026 Jefferies Global Healthcare Conference

GlobeNewswire
·
May 27

Circio and AaviGen Join Forces on Next-Generation Heart-Targeted Gene Therapies

TIPRANKS
·
May 27

FACTBOX-Pharma sector doubles down on AI amid hopes of slashing costs, timelines

Reuters
·
May 20

Blank Bio closes $7.2M seed financing, collaboration with Pacific Biosciences

TIPRANKS
·
May 19

Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

GlobeNewswire
·
May 19